Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cyberdyne Inc. (7779:JPX), powered by AI.
Cyberdyne Inc. is currently trading at ¥262. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cyberdyne Inc. on Alpha Lenz.
Cyberdyne Inc.'s P/E ratio is -98.9.
“Cyberdyne Inc. trades at a P/E of -98.9 (undervalued) with modest ROE of -1.4%. 3Y revenue CAGR of 26.8% highlights clear growth momentum.”
Ask for details →Cyberdyne Inc. is a pioneering Japanese company specializing in robotics and cybernetics technologies. The company's primary function is to develop innovative solutions that integrate advanced robotics and artificial intelligence into human society to enhance the quality of life. Cyberdyne is best known for its cutting-edge exoskeleton suits, such as the HAL (Hybrid Assistive Limb) series, designed to augment human mobility and assist with various physical tasks, including rehabilitation for patients with mobility impairments and support for heavy-duty industries. Cyberdyne's technologies have significant implications across multiple sectors, particularly in healthcare, elder care, and industrial settings, improving efficiency, safety, and quality of service. As a trailblazer in the field of robot-assistive technology, Cyberdyne plays a significant role in the global push towards smart solutions for an aging population and workforce challenges. The company's contributions extend beyond product innovation, influencing policy-making and regulatory standards for robotics utilization. Founded in 2004 and headquartered in Tsukuba, Ibaraki, Cyberdyne continues to lead advancements in humanoid robotics and wearable technology, positioning itself as a vital component of the future digital economy.
“Cyberdyne Inc. trades at a P/E of -98.9 (undervalued) with modest ROE of -1.4%. 3Y revenue CAGR of 26.8% highlights clear growth momentum.”
Ask for details →Cyberdyne Inc. (ticker: 7779) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 211 employees. Market cap is $57.1B.
The current price is 262 with a P/E ratio of -98.9x and P/B of 1.44x.
ROE is -1.44% and operating margin is -21.12%. Annual revenue is $4.4B.